A novel dosing schedule with gemcitabine, vinorelbine, and carboplatin for advanced non-small cell cancer of the lung No significant financial relationships to disclose. This is an ASCO Meeting ...
PCR-based techniques have transformed how scientists analyze transcripts’ translational applications in cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback